Cargando…
Crystal structure and Hirshfeld surface analysis of 3,4-dihydro-2-(2,4-dioxo-6-methylpyran-3-ylidene)-4-(4-pyridin-4-yl)-1,5-benzodiazepine
The title compound, C(20)H(17)N(3)O(3) [systematic name: 2-(6-methyl-2,4-dioxopyran-3-ylidene)-4-(pyridin-4-yl)-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine], is built up from a benzodiazepine ring system linked to pyridyl and pendant dihydropyran rings, where the benzene and pyridyl rings are orie...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323877/ https://www.ncbi.nlm.nih.gov/pubmed/30713742 http://dx.doi.org/10.1107/S2056989018017565 |
_version_ | 1783385859870949376 |
---|---|
author | El Ghayati, Lhoussaine Ramli, Youssef Hökelek, Tuncer Labd Taha, Mohamed Mague, Joel T. Essassi, El Mokhtar |
author_facet | El Ghayati, Lhoussaine Ramli, Youssef Hökelek, Tuncer Labd Taha, Mohamed Mague, Joel T. Essassi, El Mokhtar |
author_sort | El Ghayati, Lhoussaine |
collection | PubMed |
description | The title compound, C(20)H(17)N(3)O(3) [systematic name: 2-(6-methyl-2,4-dioxopyran-3-ylidene)-4-(pyridin-4-yl)-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine], is built up from a benzodiazepine ring system linked to pyridyl and pendant dihydropyran rings, where the benzene and pyridyl rings are oriented at a dihedral angle of 43.36 (6)°. The pendant dihydropyran ring is rotationally disordered in a 90.899 (3):0.101 (3) ratio with the orientation of each component largely determined by intramolecular N—H(Diazp)⋯O(Dhydp) (Diazp = diazepine and Dhydp = dihydropyran) hydrogen bonds. In the crystal, molecules are linked via pairs of weak intermolecular N—H(Diazp)⋯O(Dhydp) hydrogen bonds, forming inversion-related dimers with R (2) (2)(26) ring motifs. The dimers are further connected along the b-axis direction by π–π stacking interactions between the pendant dihydropyran and pyridyl rings with centroid–centroid distances of 3.833 (3) Å and a dihedral angle of 14.51 (2)°. Hirshfeld surface analysis of the crystal structure indicates that the most important contributions for the crystal packing are from H⋯H (50.1%), H⋯C/C⋯H (17.7%), H⋯O/O⋯H (16.8%), C⋯C (7.7%) and H⋯N/N⋯H (5.3%) interactions. Hydrogen-bonding and van der Waals interactions are the dominant interactions in the crystal packing. |
format | Online Article Text |
id | pubmed-6323877 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | International Union of Crystallography |
record_format | MEDLINE/PubMed |
spelling | pubmed-63238772019-02-01 Crystal structure and Hirshfeld surface analysis of 3,4-dihydro-2-(2,4-dioxo-6-methylpyran-3-ylidene)-4-(4-pyridin-4-yl)-1,5-benzodiazepine El Ghayati, Lhoussaine Ramli, Youssef Hökelek, Tuncer Labd Taha, Mohamed Mague, Joel T. Essassi, El Mokhtar Acta Crystallogr E Crystallogr Commun Research Communications The title compound, C(20)H(17)N(3)O(3) [systematic name: 2-(6-methyl-2,4-dioxopyran-3-ylidene)-4-(pyridin-4-yl)-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine], is built up from a benzodiazepine ring system linked to pyridyl and pendant dihydropyran rings, where the benzene and pyridyl rings are oriented at a dihedral angle of 43.36 (6)°. The pendant dihydropyran ring is rotationally disordered in a 90.899 (3):0.101 (3) ratio with the orientation of each component largely determined by intramolecular N—H(Diazp)⋯O(Dhydp) (Diazp = diazepine and Dhydp = dihydropyran) hydrogen bonds. In the crystal, molecules are linked via pairs of weak intermolecular N—H(Diazp)⋯O(Dhydp) hydrogen bonds, forming inversion-related dimers with R (2) (2)(26) ring motifs. The dimers are further connected along the b-axis direction by π–π stacking interactions between the pendant dihydropyran and pyridyl rings with centroid–centroid distances of 3.833 (3) Å and a dihedral angle of 14.51 (2)°. Hirshfeld surface analysis of the crystal structure indicates that the most important contributions for the crystal packing are from H⋯H (50.1%), H⋯C/C⋯H (17.7%), H⋯O/O⋯H (16.8%), C⋯C (7.7%) and H⋯N/N⋯H (5.3%) interactions. Hydrogen-bonding and van der Waals interactions are the dominant interactions in the crystal packing. International Union of Crystallography 2019-01-01 /pmc/articles/PMC6323877/ /pubmed/30713742 http://dx.doi.org/10.1107/S2056989018017565 Text en © El Ghayati et al. 2019 http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Research Communications El Ghayati, Lhoussaine Ramli, Youssef Hökelek, Tuncer Labd Taha, Mohamed Mague, Joel T. Essassi, El Mokhtar Crystal structure and Hirshfeld surface analysis of 3,4-dihydro-2-(2,4-dioxo-6-methylpyran-3-ylidene)-4-(4-pyridin-4-yl)-1,5-benzodiazepine |
title | Crystal structure and Hirshfeld surface analysis of 3,4-dihydro-2-(2,4-dioxo-6-methylpyran-3-ylidene)-4-(4-pyridin-4-yl)-1,5-benzodiazepine |
title_full | Crystal structure and Hirshfeld surface analysis of 3,4-dihydro-2-(2,4-dioxo-6-methylpyran-3-ylidene)-4-(4-pyridin-4-yl)-1,5-benzodiazepine |
title_fullStr | Crystal structure and Hirshfeld surface analysis of 3,4-dihydro-2-(2,4-dioxo-6-methylpyran-3-ylidene)-4-(4-pyridin-4-yl)-1,5-benzodiazepine |
title_full_unstemmed | Crystal structure and Hirshfeld surface analysis of 3,4-dihydro-2-(2,4-dioxo-6-methylpyran-3-ylidene)-4-(4-pyridin-4-yl)-1,5-benzodiazepine |
title_short | Crystal structure and Hirshfeld surface analysis of 3,4-dihydro-2-(2,4-dioxo-6-methylpyran-3-ylidene)-4-(4-pyridin-4-yl)-1,5-benzodiazepine |
title_sort | crystal structure and hirshfeld surface analysis of 3,4-dihydro-2-(2,4-dioxo-6-methylpyran-3-ylidene)-4-(4-pyridin-4-yl)-1,5-benzodiazepine |
topic | Research Communications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323877/ https://www.ncbi.nlm.nih.gov/pubmed/30713742 http://dx.doi.org/10.1107/S2056989018017565 |
work_keys_str_mv | AT elghayatilhoussaine crystalstructureandhirshfeldsurfaceanalysisof34dihydro224dioxo6methylpyran3ylidene44pyridin4yl15benzodiazepine AT ramliyoussef crystalstructureandhirshfeldsurfaceanalysisof34dihydro224dioxo6methylpyran3ylidene44pyridin4yl15benzodiazepine AT hokelektuncer crystalstructureandhirshfeldsurfaceanalysisof34dihydro224dioxo6methylpyran3ylidene44pyridin4yl15benzodiazepine AT labdtahamohamed crystalstructureandhirshfeldsurfaceanalysisof34dihydro224dioxo6methylpyran3ylidene44pyridin4yl15benzodiazepine AT maguejoelt crystalstructureandhirshfeldsurfaceanalysisof34dihydro224dioxo6methylpyran3ylidene44pyridin4yl15benzodiazepine AT essassielmokhtar crystalstructureandhirshfeldsurfaceanalysisof34dihydro224dioxo6methylpyran3ylidene44pyridin4yl15benzodiazepine |